October 12, 2026
Life Biosciences Reports First ER-100 Clinical Data
Sharon Rosenzweig-Lipson, PhD, discusses preliminary safety and visual field findings from the first 3 participants in a trial of epigenetic restoration therapy for optic neuropathies.








